Is Abpro Corporation (ABP) a Buy, Sell, or Hold?
Abpro Corporation
NASDAQ:ABP
$0.522 USD
$0 (0.0%)
- Volume
- 1.33M
- Average Volume
- 1.72M
- Market Capitalization
- $1.06M
- P/E Ratio
- -0.11
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $18.03
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.07
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Jin Wook Suk |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | ABP |
| CUSIP | 000847202 |
| CIK | 0001893219 |
| Web | https://abpro.com |
| Phone | 617 225 0808 |
| Currency | USD |
| Employees | 6 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -0.01 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.07 |
| Quick Ratio | 0.07 |
| Cash Ratio | 0.02 |
Sales & Book Value
| Annual Sales | $183K |
| Price / Sales | 0.00 |
| Cash Flow | -2.06 |
| Price / Cash Flow | -0.20 |
| Price / Book | -0.08 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 1 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-23.1 |
| Trailing P/E Ratio | -0.11 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-7.23M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 49.20% |
| Return on Assets | -500.76% |
Financials Score
| AltmanZ Score | -138.43 |
| Piotroski Score | 2.00 |
| Working Capital | -16.07M |
| Total Assets | 1.7M |
| Ebit | -12.79M |
| Market Cap | 1.06M |
| Total Liabilities | 17.3M |
Poll Results
About Abpro Corporation (NASDAQ:ABP) Stock
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates fr ... om its headquarters in Woburn, Massachusetts.
Frequently Asked Questions
-
What is the current Abpro Corporation (ABP) stock price?
-
Abpro Corporation(NASDAQ:ABP) stock price is $0.522 in the last trading session. During the trading session, ABP stock reached the peak price of $18.03 while $0.11 was the lowest point it dropped to. The percentage change in ABP stock occurred in the recent session was 0.0% while the dollar amount for the price change in ABP stock was $0.
-
ABP's industry and sector of operation?
-
The NASDAQ listed ABP is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ABP?
-
Jin Wook Suk | Chief Executive Officer & Chairman of the Board
Eugene Y. Chan | Co-Founder
|
|
| -
How many employees does ABP have?
-
Number of ABP employees currently stands at 6. ABP operates from 68 Cummings Park Drive, Woburn, MA 01801, US.
-
Link for ABP official website?
-
Official Website of ABP is: https://abpro.com
-
How do I contact ABP?
-
ABP could be contacted at phone #617 225 0808 and can also be accessed through its website. ABP operates from 68 Cummings Park Drive, Woburn, MA 01801, US.
-
How many shares of ABP are traded daily?
-
The average number of ABP shares traded daily for last 3 months was 1.72M.
-
What is the market cap of ABP currently?
-
The market value of ABP currently stands at $1.06M with its latest stock price at $0.522